Red light therapy and the eyes: what the vision reports show
Reviewed 19 sourcesPublished by PepVault
Red light and your eyes: the myopia trials in children, the retinal injury report, the FDA-authorized Valeda device for dry AMD, and what masks need.

- Last reviewed
- Sources
- 19
- Questions
- 8
The short answer
Red light shone into the eye is a medical treatment, not a wellness habit. In children, desktop red light devices slowed myopia in randomized trials, and one 12-year-old's retina was damaged after five months on one. For dry macular degeneration, the FDA authorized one clinic device, Valeda, in 2024, for about one line of vision. With a home panel or mask, wear the eye protection its directions name, every time.
Evidence: Mixed for slowing myopia in children: many randomized trials, mostly one year and almost all in China, which Cochrane rates very low certainty and a 2026 review of 28 trials moderate for the prescription change; low for Valeda in dry AMD (one 100-person sham-controlled pivotal trial, a benefit the FDA called of marginal clinical significance); low for aging vision and dry eye (small studies); retinal harm rests on case reports and lab measurements.

Is red light therapy safe for your eyes?
For a face mask or wall panel, the American Academy of Dermatology's advice: when the directions call for eye protection, wear the kind they name every time, and never swap sunglasses in for the goggles1. The gap: no trial has tested what years of home panel or mask sessions do to the eye itself.
What the reports show so far is rare and mostly reversible. In 2026, eye doctors in New York described a healthy 43-year-old woman whose eyes developed fluid in the tissue layers under the retina (choroidal effusions) and a sudden rise in pressure in both eyes, after two weeks of a red light mask, used that same morning too2. She took no medicines. Once she stopped the mask and was treated, her vision returned to 20/202. It is one case, and its authors call for more study of masks' eye safety2.
PepVault's side-effect log records a symptom in your own words against a compound on your protocol, with the date, a severity from 1 to 5 and a note, so a change in your eyes has a dated record to show your eye doctor. Log it in PepVault

PepVault for iPhone
Keep your protocol in PepVault
PepVault's side-effect log records a symptom in your own words against a compound on your protocol, with the date, a severity from 1 to 5 and a note, so a change in your eyes has a dated record to show your eye doctor.
7 days free on the yearly plan for new subscribers.
Can red light damage the retina?
Yes, in at least one documented case. The retina is the light-sensing layer at the back of the eye, and the fovea is its centre, where sharp vision comes from. In 2023, doctors in Shanghai reported a 12-year-old girl who had used a red laser myopia device for five months3. Her vision fell from 20/20 to 20/30 in both eyes, with afterimages that sometimes lasted more than 8 minutes318.
Scans showed a break in the layer of light-sensing cells at the fovea in both eyes318. Three months after she stopped, the damage had partly recovered and her vision was 20/253. A 2026 review co-written by Mingguang He, a director and shareholder of Eyerising, notes other changes on scans in treated children, such as brighter spots at the fovea, and calls their meaning unsettled18.
A lab at the University of Houston then measured four myopia devices against the American eye-safety standards (ANSI)4. Two of the three laser devices reached the safe exposure limit within seconds, against a 180-second treatment; the LED device took hours4. These are bench figures for a fully widened 7 mm pupil, the lab's worst case, not the light the trial children received; the Jiang trial's device was rated 0.29 mW for a 4 mm pupil45.
| Device | Light source | Time to the ANSI limit (7 mm pupil) | Safety class |
|---|---|---|---|
| EyeRising | Laser | 1.4 seconds | Class 2M laser |
| Sky-n1201 | Laser | 2.8 seconds | Class 1 laser |
| Future Vision | Laser | 253 seconds or longer | Class 1 laser |
| AirDoc | LED, diffuse | 22,761 seconds | Group 1 |
China has since reclassified red laser myopia devices as Class III medical devices4.
Does red light slow myopia in children?
Yes, and by a large margin in the trials. Myopia is nearsightedness: the eyeball grows too long, so distant things blur. The trials measure eye length in millimetres and the glasses prescription in dioptres (D), where a more negative number means more nearsighted. The devices shine 650 nm red light into the eyes for 3 minutes, twice a day567.
| Trial | Children | Schedule | After 12 months |
|---|---|---|---|
| Jiang 2022, multicentre, China5 | 264, aged 8 to 13, already nearsighted | Twice a day, 5 days a week, plus glasses | Eyes grew 0.13 mm vs 0.38 mm with glasses alone; prescription -0.20 D vs -0.79 D |
| He 2023, 10 Shanghai schools6 | 278 in grades 1 to 4, at high risk (premyopia) | Twice a day, 5 days a week | New myopia in 40.8% vs 61.3% |
| Cao 2024, Beijing7 | 336, aged 6 to 12 | Twice a day, every day | Eyes shortened 0.11 mm vs grew 0.26 mm; prescription +0.24 D vs -0.65 D |
| Cochrane review 20259 | 104 trials of all myopia treatments, 17,509 children | Pooled | Red light: 0.33 mm less growth, 0.80 D less change; very low certainty |
| Lin 2026 review10 | 28 red light trials, 3,573 children | Pooled | 0.30 mm less growth, +0.68 D |
All but one of the 28 trials in the 2026 review ran in China, and most lasted a year10. Mingguang He, an author on the Jiang, He and Xiong papers, is a director and shareholder of Eyerising and an inventor on patents for the therapy68. Cochrane rated the red light evidence very low certainty and found adverse events were not reported consistently across myopia trials9. The trials themselves found no serious harm on scans or vision tests567. In a 108-child safety study, retinal function held or improved over 12 months; some scan reflections brightened, which its authors say needs watching17.
Commonly reported: afterimages after a session and light that feels too bright; in the 336-child Cao trial, 3 children saw afterimages for a long time and 4 felt the light was strong7; a few children in other trials dropped out over lasting afterimages or uncomfortable brightness10.
What happens when children stop red light therapy?
Some of the gain comes back as faster growth. In the 2-year follow-up of the Jiang trial, 114 children were analysed. Those who stopped red light after year one grew 0.42 mm in year two, faster than children who had worn glasses all along (0.28 mm)8. Those who continued grew 0.12 mm8. Over two years, stoppers still ended slightly ahead of glasses alone, 0.50 mm against 0.64 mm8. Cochrane found too little data to judge rebound across treatments9.
Does red light improve vision as you age?
In small lab studies, colour vision sharpened for days. The idea is that cones, the colour-sensing cells, are packed with mitochondria, the cell's energy makers, and long-wavelength light helps them make energy1415. At University College London, 20 healthy people from their late 30s to 70 had one 3-minute exposure to deep red 670 nm light in one eye in the morning15.
Three hours later, their threshold for seeing blue-yellow contrast was 17% lower and red-green 12% lower, a 10-person control group with no light saw no change, and in 10 people retested the gain held a week15. The same light in the early afternoon, tested in 6 people, did nothing15. In an earlier study of people aged 28 to 72, gains appeared only from about age 4014.
Species note: the energy explanation comes from animal studies, where weeks of 650 to 900 nm light partly restored the cells' energy supply15. The human studies measured vision tests, not mitochondria, with no sham and on a lab device at a set strength.
Does red light help dry eye?
One small trial says it can. In Korea, 40 people with dry eye were randomized to a near-infrared LED device or a placebo device, twice a week for three weeks16. Damage on the eye's surface, seen with a dye, improved more than with placebo, as did tear production, with no serious side effects16. Its light was near-infrared, not red16.
Who should check with an eye doctor first?
The FDA's Valeda summary gives the clearest list, written for its own device11. It should not be used by people with known sensitivity to yellow, red or near-infrared light, or a history of light-triggered nerve conditions such as epilepsy or migraine11. Nor should anyone be treated within 30 days of a light-sensitising medicine before asking their doctor11. Safety has not been studied under age 50, in pregnancy or while nursing, or with other eye disease such as cataract11.
For skin devices, dermatologists add lupus and light-sensitising medicines to the ask-first list1. The decision about any device aimed at the eyes, for a child's myopia or an older adult's AMD, sits with the eye doctor who follows the scans.
When to get help A sudden change in vision, a blurred or dark spot in the centre, eye pain, or bright afterimages that linger after a session is a reason to stop the device and see an eye doctor the same day23.
Sources
- American Academy of Dermatology. Is red light therapy right for your skin? Last updated September 13, 2024. aad.org
- Labkovich M et al. A rare acute presentation of simultaneous bilateral angle closure in a patient using a red light therapy mask. Am J Ophthalmol Case Rep. 2026;43:102645. PubMed 42620457
- Liu H et al. Retinal damage after repeated low-level red-light laser exposure. JAMA Ophthalmol. 2023;141(7):693-695. PubMed 37227712
- Ostrin LA, Schill AW. Safety evaluation of 4 red light therapy devices for myopia. JAMA Ophthalmol. 2026;144(3):255-258. PubMed 41642586
- Jiang Y et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129(5):509-519. PubMed 34863776
- He X et al. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. JAMA Netw Open. 2023;6(4):e239612. PubMed 37099298
- Cao K et al. Daily low-level red light for spherical equivalent error and axial length in children with myopia: a randomized clinical trial. JAMA Ophthalmol. 2024;142(6):560-567. PubMed 38662345
- Xiong R et al. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study. Clin Exp Ophthalmol. 2022;50(9):1013-1024. PubMed 36054314
- Lawrenson JG et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2025;2:CD014758. PubMed 39945354
- Lin LY et al. Duration-dependent efficacy and clinical safety of repeated low-level red-light therapy for paediatric myopia: a systematic review and meta-analysis. Clin Exp Ophthalmol. 2026;54(5):630-652. PubMed 41846466
- FDA. De Novo classification request DEN230083, Valeda Light Delivery System (decision summary). accessdata.fda.gov
- Boyer D et al. LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the LumiThera Valeda Light Delivery System. Retina. 2024;44(3):487-497. PubMed 37972955
- Jaffe GJ et al. Long-term efficacy and safety of photobiomodulation in dry age-related macular degeneration (LIGHTSITE III: 24-month analysis). Retina. 2026;46(5):783-795. PubMed 41791029
- Shinhmar H et al. Optically improved mitochondrial function redeems aged human visual decline. J Gerontol A Biol Sci Med Sci. 2020;75(9):e49-e52. PubMed 32596723
- Shinhmar H et al. Weeklong improved colour contrasts sensitivity after single 670 nm exposures associated with enhanced mitochondrial function. Sci Rep. 2021;11:22872. PubMed 34819619
- Park Y et al. Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial. Sci Rep. 2022;12:3575. PubMed 35246565
- Zhu M et al. Safety of repeated low-level red-light therapy for children with myopia. Photodiagnosis Photodyn Ther. 2024;47:104198. PubMed 38729232
- Wu Y et al. Repeated low-level red-light therapy for myopia control: an update on efficacy and safety. Taiwan J Ophthalmol. 2026;16(2):246-255. PubMed 42549280
- openFDA device record DEN230083 (Valeda Light Delivery System, Lumithera, product code SDE, decision November 4, 2024), queried November 20, 2026. api.fda.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.